MetLife shares barely moved, closing at $96.41 on August 5, up 0.2%. The latest filing offers a straightforward first impression: the insurer sold more, earned more from operations, and saw its margins move in different directions.
Revenue rose 10.5% to $19.2 billion in the three months ended June 30. Operating income climbed 15.1% to $1.6 billion, lifting the operating margin to 8.4% from 8.0% a year earlier. The stock is also up 25.4% over six months, so the filing arrives after a meaningful run rather than into an empty room.
The less tidy part is below operating income. Net income increased just 1.0%, from $729 million to $736 million, and net margin slipped to 3.8% from 4.2%. Diluted EPS still rose 5.8% to $1.09, helped by a 4.2% reduction in diluted shares to 646.9 million.
Management described the revenue increase as a sales-and-renewals story, with the comparison excluding foreign-exchange movements:
"Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $89 million, or 12%, compared to the prior period primarily due to strong sales and solid renewal activity across the region."
10-Q 2026-08-06
That gives the top-line expansion a concrete operating explanation. It also leaves the bottom-line gap intact: stronger sales and renewals accompanied the top-line expansion, but the filing does not identify a single reason why only $7 million reached net income.
The company’s adjusted measure tells a more favorable part of the same story. MetLife said adjusted earnings available to common shareholders increased $211 million on a reported basis, driven by underwriting and other insurance adjustments, higher market factors, and volume growth, with higher expenses offsetting some of the increase.
"Adjusted earnings available to common shareholders increased $211 million on a reported basis primarily due to favorable underwriting and other insurance adjustments, higher market factors and volume growth, partially offset by higher expenses."
10-Q 2026-08-06
Adjusted earnings are not net income, which is why both numbers can be true without resolving the discrepancy. The filing shows an insurer with more operating volume and better reported underwriting-related factors, alongside a reported bottom line that was nearly flat.
Cash adds another complication. MetLife’s cash balance fell 13.0% to $19.3 billion from $22.2 billion a year earlier. The filing does not disclose the reason for that change in the supplied comparison, so it is a balance-sheet fact rather than an explanation for the earnings spread.
The longer record provides one useful piece of context: MetLife’s latest annual results show revenue growth of 8.5% in 2025, while foreign exchange has appeared as a favorable factor across five filings. That makes the current sales and renewal language look like part of an operating pattern, though the latest quarter’s net-of-currency figure is the cleaner measure of underlying growth.
The unresolved question is not whether MetLife grew. It did. The question is how much of that growth keeps reaching net income after the adjustments and market factors that helped adjusted earnings this time. MetLife’s next quarterly report will put the latest result beside the $736 million of net income reported for these three months.